Trials / Conditions / Pheochromocytoma/Paraganglioma (PPGL)
Pheochromocytoma/Paraganglioma (PPGL)
3 registered clinical trials studyying Pheochromocytoma/Paraganglioma (PPGL) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146 | National Cancer Institute (NCI) | Phase 2 |
| Enrolling By Invitation | Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors NCT07182175 | Peking University First Hospital | — |
| Recruiting | Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma NCT07288931 | Peking Union Medical College Hospital | N/A |